Live Breaking News & Updates on Secarna

Stay updated with breaking news from Secarna. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Secarna Pharmaceuticals GmbH & Co. KG: Secarna Pharmaceuticals Announces Publication of New Preclinical Data Showing Durable Antitumor Activity of LNAplus-Based ASOs that Both Stimulate the Innate Immune System and Suppress PD-L1 Expression

Compelling in vivo and in vitro data published in peer-reviewed Journal for ImmunoTherapy of Cancer (JITC)Secarna's LNAplus-based ASOs effectively stimulate TLR9 signaling, an important innate immune pathway ....

Mecklenburg Vorpommern , Alexander Gebauer , Stefan Klotter , Alfred Zippelius , Frank Jaschinski , Planegg Martinsried , Mikael Pittet , Anne Hennecke Lydia Robinson Garcia , Department Of Pathology , Secarna Pharmaceuticals , Mc Services , Department Of Biomedicine , University Of Geneva , Basel University , Secarna Pharmaceuticals Gmbh Co , Secarna Pharmaceuticals Gmbh , Chief Scientific Officer , Stabile Ertr , Chart Profi Stefan Klotter , Blue Chips ,

DGAP-News: First subject dosed in Lipigon's phase I clinical study with antisense oligonucleotide candidate derived from Secarna Pharmaceutical's LNAplus™ technology platform

DGAP-News: Secarna Pharmaceuticals GmbH & Co. KG / Key word(s): Study First subject dosed in Lipigon’s phase I clinical study with antisense oligonucleotide candidate derived from Secarna Pharmaceutical’s LNAplus™ technology platform 31.05.2022 / 14:00 The issuer is solely responsible for th. ....

Anne Hennecke Brittney Sojeva , Alexander Gebauer , Planegg Martinsried , Secarna Lnaplus , Lipigon Pharmaceuticals Ab , Secarna Pharmaceuticals Gmbh Co , Mc Services , Swedish Medical Products Agency , Secarna Pharmaceuticals , Distribution Services , Secarna Pharmaceuticals Gmbh , Secarna Pharmaceutical , Familial Chylomicronemia Syndrome , Lipigon Pharmaceuticals , Denali Therapeutics , Corporate News , Regulatory Announcements , Dgap News , Ipigon S , Harmaceutical S ,

DGAP-News: Secarna Pharmaceuticals' strategic partner Evotec achieves programme designation in neuroscience collaboration with Bristol Myers Squibb

DGAP-News: Secarna Pharmaceuticals GmbH & Co. KG / Key word(s): Miscellaneous 12.04.2022 / 14:00 The issuer is solely responsible for the content of this announcement. Secarna Pharmaceuticals strategic partner Evotec achieves programme designation in neuroscience collaboration with Bristo. ....

Anne Hennecke Vera Lang , Shinya Yamanaka , Planegg Martinsried , Alexander Gebauer , John Gurdon , Secarna Lnaplus , Bristol Myers Squibb , Secarna Pharmaceuticals Gmbh Co , Mc Services , Secarna Pharmaceuticals , Evotec Se Frankfurt Stock Exchange , Distribution Services , Secarna Pharmaceuticals Gmbh , Bristol Myers , Pharmaceuticals Gmbh , Frankfurt Stock Exchange , Sir John Gurdon , Corporate News , Regulatory Announcements , Dgap News , Pharmaceuticals ,

DGAP-News: Secarna Pharmaceuticals' partner Denali Therapeutics exercises option for LNAplusTM antisense oligonucleotide development program in neurodegeneration

DGAP-News: Secarna Pharmaceuticals GmbH & Co. KG / Key word(s): Expansion Secarna Pharmaceuticals partner Denali Therapeutics exercises option for LNAplusTM antisense oligonucleotide development program in neurodegeneration 22.02.2022 / 14:00 The issuer is solely responsible for the content. ....

Anne Hennecke Vera Lang , Planegg Martinsried , Alexander Gebauer , Secarna Asos , Secarna Lnaplus , Secarna Pharmaceuticals Gmbh Co , Mc Services , Denali Therapeutics Inc , Secarna Pharmaceuticals , Research Collaboration , Distribution Services , Secarna Pharmaceuticals Gmbh , Denali Therapeutics , Oligonucleotide Transport Vehicle , Pharmaceuticals Gmbh , Option Agreement , South San , Corporate News , Regulatory Announcements , Dgap News , Pharmaceuticals ,

DGAP-News: Secarna Pharmaceuticals and Denali Therapeutics expand strategic partnership for the discovery and development of novel ASO therapeutics in the field of CNS diseases

DGAP-News: Secarna Pharmaceuticals GmbH & Co. KG / Key word(s): Agreement Secarna Pharmaceuticals and Denali Therapeutics expand strategic partnership for the discovery and development of novel ASO therapeutics in the field of CNS diseases 26.10.2021 / 15:00 The issuer is solely responsible . ....

Anne Hennecke Vera Lang , Alexander Schuth , Planegg Martinsried , Alexander Gebauer , Secarna Pharmaceuticals Gmbh Co , Mc Services , Denali Therapeutics Inc , Secarna Pharmaceuticals , Research Collaboration , Distribution Services , Secarna Pharmaceuticals Gmbh , Denali Therapeutics , Transport Vehicle , Pharmaceuticals Gmbh , Option Agreement , Oligonucleotide Transport Vehicle , South San , Corporate News , Regulatory Announcements , Dgap News ,